![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GRANDIX PHARMACEUTICALS PACT WITH ITALIAN FIRM
GRANDIX PHARMACEUTICALS PACT WITH ITALIAN FIRM
August 26, 2005
Grandix Pharmaceuticals Ltd. said Friday that the company has tied up with Italian diagnostics major Chromogenix for distributing select products in India. Under the agreement, Grandix will market Chromogenic Substrates' entire portfolio of more than 70 products in the field of coagulation and fibrinolysis through out India. Chromegenic Substrates will be used widely in pharmaceuticals and research and development labs, biotechnology companies, blood banks, clinical laboratories and hospitals for various diagnostics purposes.
New Kerala (http://www.newkerala.com/news.php?action=fullnews&id=17301)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct